Urate Lowering With Combination Therapy in CKD: Reason for Optimism or Einstein's Definition of Insanity?

Am J Kidney Dis. 2021 Apr;77(4):478-480. doi: 10.1053/j.ajkd.2020.11.007. Epub 2021 Feb 7.

Authors

Diana I Jalal¹, Glenn M Chertow²

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, Carver College of Medicine, Iowa City, Iowa. Electronic address: diana-jalal@uiowa.edu.
² Division of Nephrology, Departments of Medicine and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.

PMID: 33568321
DOI: 10.1053/j.ajkd.2020.11.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Albuminuria
Diabetes Mellitus, Type 2*
Febuxostat
Humans
Naphthalenes
Propionates
Pyridines
Renal Insufficiency, Chronic* / diagnosis
Renal Insufficiency, Chronic* / therapy
Uric Acid

Substances

Naphthalenes
Propionates
Pyridines
Febuxostat
verinurad
Uric Acid